외과용 드레싱 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global surgical dressing market size reached USD 4.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.64% during 2025-2033. The growing prevalence of chronic wounds, ulcers, and burns, a considerable rise in the uptake of organ transplant procedures, and the increasing health consciousness among the masses represent some of the key factors driving the market.

Surgical dressing refers to any fibrous material that is used to provide protection to exposed tissues and keep wounds in a hygienic and proper manner. Usually made from fibres as well as fabrics, gauze, lint, and plasters, it is placed over a wound as a protective covering. Surgical dressings include sterile pads, compress, or composite waterproof multi-layered bandages, which are most commonly used as a wound covering. A surgical dressing, as opposed to a bandage, is formulated to be in direct contact with the wound, and most of them are self-adhesive. Three-layer surgical dressings contain semi- or non-adherent lower layers to infuse water into the following layer, while preventing it from sticking to the granulated tissue. In addition to protecting the wound from mechanical damage and absorbing drainage, surgical dressings protect the wound from contamination by bodily discharges, such as feces and urine, provide a physiologic environment conducive to healing, and offer mental and physical comfort for the patient.

Surgical Dressing Market Trends:

The growing prevalence of chronic wounds, ulcers, and burns across the globe is a significant factor that is driving the market. This can be attributed to the rising number of chronic health conditions as well as sedentary lifestyle and poor dietary patterns adopted by the masses. In line with this, a considerable rise in the uptake of organ transplant procedures, particularly knee and hip replacement surgeries requiring intensive care, is also providing an impetus to the market. Moreover, the expanding number of ambulatory surgery centers and specialty clinics for affordable outpatient procedures is creating lucrative growth opportunities in the market. The market is further fueled by the increasing incidences of road accidents, which is resulting in a higher uptake of surgical dressings. Besides this, the growing geriatric population that is more susceptible to chronic wounds and slower healing ability is creating a positive outlook for the market. Furthermore, continual technological developments in the treatment services involving surgical procedures and pain management are impacting the market positively. Favorable healthcare initiatives undertaken by the government bodies of several countries promoting affordability and sanitized facilities are also propelling the market. Some of the other factors contributing to the market include the rising healthcare expenditure, the augmenting popularity of minimally invasive surgeries, the increasing number of cardiovascular disease-related surgeries, and easy product availability across online and offline organized retail channels.

Key Market Segmentation:

Product Insights

Primary Dressing

Film Dressing

Hydrogel Dressing

Hydrocolloid Dressing

Foam Dressing

Alginate Dressing

Others

Secondary Dressing

Absorbents

Bandages

Adhesive Tapes

Protectives

Others

Others

Application Insights

Ulcers

Burns

Organ Transplants

Cardiovascular Disease

Diabetes Based Surgeries

Others

End User Insights

Hospital

Specialty Clinics

Home Healthcare

Ambulatory Surgery Centers

Others

Regional Insights

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for surgical dressing. Some of the factors driving the North America surgical dressing market include the increasing geriatric population, rising healthcare expenditure, expanding number of hospital chains and healthcare facilities etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global surgical dressing market. Detailed profiles of all major companies have also been provided. Some of the companies covered include 3M Company, Advancis Medical, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, Convatec Group plc, DeRoyal Industries Inc., Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew Plc, etc.

Key Questions Answered in This Report:

• How has the global surgical dressing market performed so far and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global surgical dressing market?
• What are the key regional markets?
• Which countries represent the most attractive surgical dressing markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What is the competitive structure of the global surgical dressing market?
• Who are the key players/companies in the global surgical dressing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Surgical Dressing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Primary Dressing
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Film Dressing
    • 6.1.2.2 Hydrogel Dressing
    • 6.1.2.3 Hydrocolloid Dressing
    • 6.1.2.4 Foam Dressing
    • 6.1.2.5 Alginate Dressing
    • 6.1.2.6 Others
  • 6.1.3 Market Forecast
• 6.2 Secondary Dressing
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Absorbents
    • 6.2.2.2 Adhesive Tapes
    • 6.2.2.3 Protectives
    • 6.2.2.4 Others
  • 6.2.3 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Ulcers
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Burns
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Organ Transplants
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Cardiovascular Disease
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Diabetes Based Surgeries
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospital
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Specialty Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Home Healthcare
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Ambulatory Surgery Centers
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3M Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Advancis Medical
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 B. Braun Melsungen AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Cardinal Health Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Coloplast A/S
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Convatec Group plc
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 DeRoyal Industries Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Molnlycke Health Care AB
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 SWOT Analysis
  • 14.3.9 Paul Hartmann AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Smith & Nephew Plc
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.